Literature DB >> 11836355

Current status of human chromosome 14.

D Kamnasaran1, D W Cox.   

Abstract

Over the past three decades, extensive genetic, physical, transcript, and sequence maps have assisted in the mapping of over 30 genetic diseases and in the identification of over 550 genes on human chromosome 14. Additional genetic disorders were assigned to chromosome 14 by studying either constitutional or acquired chromosome aberrations of affected subjects. Studies of benign and malignant tumours by karyotype analyses and by allelotyping with a panel of polymorphic genetic markers have further suggested the presence of several tumour suppressor loci on chromosome 14. The search for disease genes on human chromosome 14 has also been achieved by exploiting the human-mouse comparative maps. Research on uniparental disomy and on the search for imprinted genes has supported evidence of epigenetic inheritance as a result of imprinting on human chromosome 14. This review focuses on the current developments on human chromosome 14 with respect to genetic maps, physical maps, transcript maps, sequence maps, genes, diseases, mouse-human comparative maps, and imprinting.

Entities:  

Mesh:

Year:  2002        PMID: 11836355      PMCID: PMC1735028          DOI: 10.1136/jmg.39.2.81

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  117 in total

1.  A linkage map of human chromosome 14, including 13 gene loci.

Authors:  D W Cox; G Billingsley; V T Nguyen
Journal:  Genomics       Date:  1994-09-15       Impact factor: 5.736

2.  The EUROGEM map of human chromosome 14.

Authors:  J Attwood; T Kruse; G Vergnaud; P Malaspina; S Povey
Journal:  Eur J Hum Genet       Date:  1994       Impact factor: 4.246

3.  Report of the first international workshop on human chromosome 14 mapping 1993.

Authors:  D W Cox
Journal:  Cytogenet Cell Genet       Date:  1994

4.  Allelotype of endometrial carcinoma.

Authors:  T Fujino; J I Risinger; N K Collins; F S Liu; H Nishii; H Takahashi; E M Westphal; J C Barrett; H Sasaki; M F Kohler
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

5.  Regional localization of loci on chromosome 14 using somatic cell hybrids.

Authors:  G D Billingsley; D W Cox; A M Duncan; P J Goodfellow; K H Grzeschik
Journal:  Cytogenet Cell Genet       Date:  1994

Review 6.  Trisomy 14 in hematologic diseases. Another non-random abnormality within myeloid proliferative disorders.

Authors:  M Mancini; M Cedrone; M Nanni; M B Rondinelli; M C Petti; M R De Cuia; G Alimena
Journal:  Cancer Genet Cytogenet       Date:  1993-03

7.  Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas.

Authors:  J Young; B Leggett; M Ward; L Thomas; R Buttenshaw; J Searle; G Chenevix-Trench
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

Review 8.  Natural history of mosaic trisomy 14 syndrome.

Authors:  A Fujimoto; J Allanson; C A Crowe; M H Lipson; V P Johnson
Journal:  Am J Med Genet       Date:  1992-09-15

Review 9.  Myelodysplastic syndrome and trisomy 14q.

Authors:  P Tumewu; G Royle
Journal:  Cancer Genet Cytogenet       Date:  1992-11

10.  Physical mapping of four serpin genes: alpha 1-antitrypsin, alpha 1-antichymotrypsin, corticosteroid-binding globulin, and protein C inhibitor, within a 280-kb region on chromosome I4q32.1.

Authors:  G D Billingsley; M A Walter; G L Hammond; D W Cox
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

View more
  8 in total

1.  Microsatellite genotyping of chromosome 14q13.2-14q13 in the vicinity of proteasomal gene PSMA6 and association with Graves' disease in the Latvian population.

Authors:  Tatjana Sjakste; Jelena Eglite; Arturs Sochnevs; Mara Marga; Valdis Pirags; Yrjö Collan; Nikolajs Sjakste
Journal:  Immunogenetics       Date:  2004-06-17       Impact factor: 2.846

Review 2.  Epigenetics and human disease: translating basic biology into clinical applications.

Authors:  David Rodenhiser; Mellissa Mann
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

3.  Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.

Authors:  Xiaoqing Cheng; Yuan Hao; Wenjie Shu; Mengjie Zhao; Chen Zhao; Yuan Wu; Xiaodan Peng; Pinfang Yao; Daibiao Xiao; Guoliang Qing; Zhengying Pan; Lei Yin; Desheng Hu; Hai-Ning Du
Journal:  J Biol Chem       Date:  2017-04-25       Impact factor: 5.157

4.  The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.

Authors:  Zhangguo Chen; Catherine T Yan; Yali Dou; Sawanee S Viboolsittiseri; Jing H Wang
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

5.  Interstitial 14q24.3 to q31.3 deletion in a 6-year-old boy with a non-specific dysmorphic phenotype.

Authors:  Mariluce Riegel; Lilia Ma Moreira; Layla D Espirito Santo; Maria Betânia P Toralles; Albert Schinzel
Journal:  Mol Cytogenet       Date:  2014-11-19       Impact factor: 2.009

Review 6.  Guideline recommendations for diagnosis and clinical management of Ring14 syndrome-first report of an ad hoc task force.

Authors:  Berardo Rinaldi; Alessandro Vaisfeld; Sergio Amarri; Chiara Baldo; Giuseppe Gobbi; Pamela Magini; Erto Melli; Giovanni Neri; Francesca Novara; Tommaso Pippucci; Romana Rizzi; Annarosa Soresina; Laura Zampini; Orsetta Zuffardi; Marco Crimi
Journal:  Orphanet J Rare Dis       Date:  2017-04-11       Impact factor: 4.123

Review 7.  Epigenetics of human diseases and scope in future therapeutics.

Authors:  Monis B Shamsi; Abdul S Firoz; Syed N Imam; Naweed Alzaman; Muhammad A Samman
Journal:  J Taibah Univ Med Sci       Date:  2017-05-22

8.  Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma.

Authors:  Meeta P Pradhan; Akshay Desai; Mathew J Palakal
Journal:  BMC Syst Biol       Date:  2013-12-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.